COGT
Cogent Biosciences, Inc. · Healthcare · Biotechnology
Input momentum (manajer yang sebanding):
keluasan pemegang +20.0% ·
aliran saham +3.8% ·
posisi baru bersih +16.7%
— formula
Akumulasi luas — peningkatan saham di lebih banyak pemegang
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q3 2024
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 104 | +4 | 108.47M | $4.20B | +7 | −3 |
| Q1 2026 | 103 | +9 | 108.14M | $4.02B | +15 | −6 |
| Q4 2025 | 92 | +1 | 96.22M | $3.42B | +1 | — |
| Q3 2025 | 20 | +4 | 59.75M | $857.99M | +4 | — |
| Q2 2025 | 13 | -2 | 45.58M | $327.23M | — | −2 |
| Q1 2025 | 12 | -1 | 13.98M | $83.77M | — | −1 |
| Q4 2024 | 13 | 0 | 17.19M | $134.06M | +1 | −1 |
| Q3 2024 | 12 | +2 | 19.61M | $211.75M | +2 | — |
| Q2 2024 | 10 | — | 18.90M | $159.29M | — | — |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Point72 Asset Management ✦ | 10.47M | 0.0% | $113.08M | 0.4% | Held | 2 | SEC ↗ |
| 2 | Adage Capital Partners ✦ | 4.07M | -4.3% | $43.91M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 3 | Geode Capital Management ✦ (pasif) | 2.28M | +15.2% | $24.64M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | Geode Capital Management ✦ (pasif) | 2.28M | +15.2% | $24.64M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | Millennium Management ✦ | 1.61M | +31.0% | $17.43M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | D. E. Shaw & Co. ✦ | 457.23K | +53.1% | $4.94M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | D. E. Shaw & Co. ✦ | 457.23K | +53.1% | $4.94M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | Wellington Management ✦ | 342.32K | +8.0% | $3.70M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | Wellington Management ✦ | 342.32K | +8.0% | $3.70M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | Wellington Management ✦ | 342.32K | +8.0% | $3.70M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | Wellington Management ✦ | 342.32K | +8.0% | $3.70M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | Fisher Asset Management ✦ | 129.41K | -13.2% | $1.40M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | Two Sigma Investments ✦ | 106.62K | -28.6% | $1.15M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | Marshall Wace ✦ | 73.91K | Baru | $798,174 | 0.0% | New | 1 | SEC ↗ |
| 15 | T. Rowe Price ✦ | 44.16K | +8.7% | $477,000 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 11.71K | Baru | $126,489 | 0.0% | New | 1 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 11.71K | Baru | $126,489 | 0.0% | New | 1 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 11.71K | Baru | $126,489 | 0.0% | New | 1 | SEC ↗ |
| 19 | Citadel Advisors ✦ | 9.65K | +6.7% | $104,188 | 0.0% | ▲ Add | 2 | SEC ↗ |
"Bobot mereka" = porsi posisi dari total nilai ekuitas 13F yang dilaporkan manajer tersebut — ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Marshall Wace | $798,174 | 0.0% |
| AQR Capital Management | $126,489 | 0.0% |
| AQR Capital Management | $126,489 | 0.0% |
| AQR Capital Management | $126,489 | 0.0% |
Telah keluar
| Tidak ada keluar yang terlacak kuartal ini. |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 304 pemegang, 186.07M saham, $6.90B dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang efek ini yang dilacak — berdasarkan jumlah kepemilikan bersama, bukan hubungan fundamental.